Bluejay Capital Partners recapitalizes Quality Life Science Logistics & Transportation to expand cold chain logistics capabilities
Key takeaways
- Bluejay Capital recapitalized QLS, a cold chain transportation company.
- QLS focuses on dual temperature trailers to safely transport high-value pharmaceutical cargo.
- The partnership aims to expand market reach while maintaining QLS’s mission, culture, and service quality.
Bluejay Capital Partners recently announced the recapitalization of Quality Life Science Logistics & Transportation (QLS). QLS, which provides specialized cold chain transportation and logistics solutions, focused on handling refrigerated, frozen, and ambient high-value pharmaceutical and life sciences cargo.
QLS specializes in dual-temperature trailers designed to maintain the integrity and security of life-saving products throughout the supply chain.
Bluejay Capital financed the transaction with Revelation Partners, the largest secondaries investment manager providing flexible capital solutions exclusively to the private health care ecosystem, and Oxford Finance, a specialty finance firm with experience in health care and business services. McGuireWoods LLP served as legal counsel to Bluejay Capital.
“Our partnership with Bluejay Capital marks the beginning of the next chapter of growth for QLS and our dedicated employees,” said Terry Fewless, founder of QLS, who will retain an ownership stake in the business. “Our core values, mission, and culture will not change. We are proud of what we have created and are excited to advance our industry-leading position and expand our market reach. The Bluejay team is definitely the right partner for QLS.”
This piece was created with the assistance of generative AI tools and was edited by our content team for clarity and accuracy.